Equilibrium studies of cytidine for chloride substitution in palladium complexes

Equilibrium constants for substitution of Cl^? by cytidine in PdCl^42? and Pd(en)Cl² in aqueous solution were determined. Equilibrium constants for substitution of Cl^? by pyridine in Pd(en)Cl₂ were also measured. For unit ionic strength at 25°C, log K values for the successive substitutions of two chlorides are: PdCl₄^2? -cytidine, log K₁ = 4.49, log K₂ = 3.45; Pd(en)Cl₂-cytidine, log K₁ = 3.32, log K₂ = 2.56; Pd(en)Cl₂-pyridine, log K₁ = 4.31, log K₂ = 3.15. Comparison of equilibrium constants indicates that intramolecular hydrogen bonding and steric interactions of the exocyclic substituents ortho to the binding site of cytidine do not contribute significantly to the stability of the palladium-nucleoside complexes. Coordination equilibria, of deprotonated cytidine occur in alkaline solutions of PdCl₄^2? and the ligand.     

Some biochemical aspects of the protective effect of strontium chloride on γ-irradiated rats

The effect of treatment with SrCl₂ (10 mg 100 g^–) on rats 15 min prior to whole body -irradiation (7.5 Gy) was studied. The hazardous effects of irradiation were greatly corrected in the treated group. The hyperglycemic effect and liver glycogen accumulation in the untreated group decreased to normal level. The enzymatic activities of serum alkaline phosphatase, alanine and aspartate aminotransferases, and lactate dehydrogenase were greatly affected, showing insignificant changes in the treated group of animals. Life span calculated on 50% survival was also significantly elongated by 36.3%. These results show the potentiality of SrCl₂ as a radioprotective agent. A proposed mechanism is discussed.     

Development of palladium L-edge X-ray absorption spectroscopy and its application for chloropalladium complexes

X-ray absorption spectroscopy (XAS) is a synchrotron-based experimental technique that provides information about geometric and electronic structures of transition metal complexes. Combination of metal L-edge and ligand K-edge XAS has the potential to define the complete experimental ground state electronic structures for metal complexes with unoccupied d manifolds. We developed a quantitative treatment for Pd L-edge spectroscopy on the basis of the well-established chlorine K-edge XAS for a series of chloropalladium complexes that are pre-catalysts in various organic transformations. We found that Pd-Cl bonds are highly covalent, such as 24 ± 2%, 34 ± 3%, and 48 ± 4% chloride 3p character for each Pd-Cl bond in [PdCl₄]²⁻, [PdCl₆]²⁻, and PdCl₂, respectively. Pd(2p → 4d) transition dipole integrals of 20.8 (SSRL)/16.9 (ALS) eV and 14.1 (SSRL)/11.9 (ALS) eV were determined using various combinations of L-edges for Pd^(II) and Pd^(IV), respectively. Application of metal-ligand covalency and transition dipole integrals were demonstrated for the example of bridging chloride ligands in PdCl₂. Our work lays the foundation for extending the quantitative treatment to other catalytically important ligands, such as phosphine, phosphite, olefin, amine, and alkyl in order to correlate the electronic structures of palladium complexes with their catalytic activity.     

Synthesis, characterization and structural studies of new palladium(II) complexes including non-symmetric phosphorus ylides

The reaction of the non-symmetric phosphorus ylides, Ph₂P(CH₂)_nPPh₂C(H)C(O)PhR [Y₁-Y₄: n = 1, R = Cl, Br, NO₂, OCH₃ and Y₅-Y₈: n = 2, R = Cl, Br, NO, OCH₃] with dichloro(1,5-cyclooctadiene)palladium(II) in dichloromethane under mild conditions afford the monomeric P-C chelated complexes, [(Y)PdCl₂] (Y = Y₁-Y₈). These complexes were fully characterized by elemental analysis and spectroscopic techniques such as IR, ¹H, ³¹P, and ¹³C NMR. In addition, the identity of complexes [(Y₅)PdCl₂] (1b) and [(Y₈)PdCl₂] (4b) was unequivocally determined by single crystal X-diffraction techniques, both structures consisting of six-membered rings formed by coordination of the ligands through the phosphine group and the ylidic carbon atom to the metal center. The coordination geometry around the Pd atoms in both these complexes be defined as slightly distorted square planar. Furthermore, their electrochemical behavior was also investigated by cyclic voltammeters, thus the cyclic voltammetry of complex [(Y₁)PdCl₂], in dichloromethane solution with Pt electrode, shows that the redox reaction of the pair Pd(II)/Pd(0) is irreversible with the cathodic peak potential at −1.08 V versus Ag wire.     

Synthesis of new palladium(II) complexes containing tetradentate-nitrogen donor ligands: Combined structural studies by NMR spectroscopy and X-ray crystallography

Treatment of the tetradentate (NN′N′N) N-alkylaminopyrazole ligands 3,6-dimethyl-1,8-(3,5-dimethyl-1-pyrazolyl)-3,6-diazaoctane (ddad) and 1,4-bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]piperazine (bedp) with [PdCl₂(CH₃CN)₂] in a 1:1 M/L ratio in acetonitrile produces [Pd₂Cl₄(L)] and [PdCl₂(L)] (L = ddad and bedp). Treatment of the corresponding complex [PdCl₂(L)] (L = ddad, bedp) in the presence of AgBF₄ in CH₂Cl₂/methanol (2:1) or NaBF₄ in acetonitrile gives [Pd(L)](BF₄)₂. The Pd(II) complexes have been characterised by elemental analyses, conductivity measurements, IR and ¹H and ¹³C{¹H} NMR spectroscopies when possible. The X-ray structure of the complex [Pd(ddad)]Cl₂ · 3H₂O has been determined. The Pd(II) is coordinated to the ddad ligand by two nitrogen atoms of pyrazolyl groups and two nitrogen atoms of the amine groups, in a slightly distorted square-planar geometry.     

Synthesis and characterisation of palladium(II) and platinum(II) compounds containing pyrazole-derived ligands: crystal structure of [PdCl2(HL)] (HL = 3-phenyl-5-(2-pyridyl)pyrazole)

Reaction of the ligands 3-phenyl-5-(2-pyridyl)pyrazole (HL¹), 3,5-bis(2-pyridyl)pyrazole (HL²), 3-methyl-5-(2-pyridyl)pyrazole (HL³) and 3-methyl-5-phenylpyrazole (HL⁴) with [MCl₂(CH₃CN)₂] (M = Pd(II), Pt(II)) or [PdCl₂(cod)] gives complexes with stoichiometry [PdCl₂(HL)₂] (HL = HL¹, HL², HL³), [Pt(L)₂] (L = L¹, L², L³) and [MCl₂(HL⁴)₂] (M = Pd(II), Pt(II)). The new complexes were characterised by elemental analyses, conductivity measurements, infrared and ¹H NMR spectroscopies. The crystal and molecular structure of [PdCl₂(HL¹)] was resolved by X-ray diffraction, and consists of monomeric cis-[PdCl₂(HL¹)] molecules. The palladium centre has a typical square planar geometry, with a slight tetrahedral distortion. The tetra-coordinated metal atom is bonded to one pyridine nitrogen, one pyrazolic nitrogen and two chloro ligands in a cis disposition. The ligand HL¹ is not completely planar.     

Synthesis and spectroscopy of diethyl (pyridinylmethyl)phosphates and their palladium (II) complexes: X-ray crystal structures of Pd(II) complexes

The synthesis of diethyl (pyridin-2-, -3-, -4-ylmethyl)phosphate (2-pmOpe, 3-pmOpe, 4-pmOpe) ligands and their palladium (II) complexes of general formula trans-[PdCl₂L₂] (L = 2-pmOpe, 3-pmOpe,4-pmOpe) has been described. Pyridine phosphate derivatives were synthesized via the condensation of phosphorochloridic acid diethyl ester with an appropriate pyridinylmethanol in the presence of triethylamine. The compounds have been identified and characterized by IR, far-IR, ¹H NMR, ³¹P NMR, ³¹P CP-MAS NMR and elemental analyses. The crystal and molecular structures of palladium (II) complexes, i.e., [PdCl₂(2-pmOpe)₂] and [PdCl₂(4-pmOpe)₂] determined by the X-ray diffraction method, are presented. In both structures, Pd(II) ions are four-coordinated by two chlorine atoms and two pyridine nitrogen atoms. The geometry of complexes is square-planar and adopt a trans configuration, which is consistent with preparation method.     

Synthesis and characterisation of pyrazolic palladium compounds containing alcohol functionality:: rotation around the Pd-N bond

The ligands 1-hydroxymethylpyrazole (hl¹), 1-(2-hydroxyethyl)pyrazole (hl²) and 1-(3-hydroxypropyl)pyrazole (hl³) react with [PdCl₂(CH₃CN)₂] to give trans-[PdCl₂(hl)₂] compounds. Due to a hindered rotation around the Pd-bond, these compounds present two different conformations in solution: anti and syn. The conformation presented depends on the relative disposition of the hydroxyalkylic chains of the two pyrazolic ligands. The present study was carried out on the basis of NMR experiments. The present paper reports the crystal structure of trans-[PdCl₂(hl²)₂]. The synthesis and characterisation of compounds [Pd(hl)₄](BF₄)₂ (hl = hl¹, hl² and hl³) starting from [Pd(CH₃CN)₄](BF₄)₂ and the corresponding chlorocomplexes trans-[PdCl₂(hl)₂] are also described.     

Transfer of 85Sr and 134Cs from diet to reindeer foetuses and milk

Sr-85 and ¹³⁴Cs in aqueous solution of the chlorides were administered daily to four pregnant reindeer during the last part of gestation. Radionuclide concentrations were determined in calves sacrificed at birth, and secretion of the nuclides was measured in milk. Although the gastrointestinal absorption of ⁸⁵Sr was low, an apparently higher transfer of the absorbed fraction of ⁸⁵Sr than ¹³⁴Cs from the mother to the foetus led to similar accumulation of ⁸⁵Sr and ¹³⁴Cs in foetuses. At birth 1.4–1.6 and 1.5–2.5% of the total administered activities of ⁸⁵Sr and ¹³⁴Cs, respectively, were present in the calves‘ bodies. Transfer coefficients (F _m) for ⁸⁵Sr and ¹³⁴Cs from feed to milk were estimated at 0.0218±0.0026 and 0.185±0.025 day kg⁻¹, respectively, and the observed ratio (OR_milk-diet) for ⁸⁵Sr was 0.124±0.037. Transfer of radiostrontium to reindeer milk was in agreement with previously reported relationships between Ca intake and radiostrontium transfer in ruminants. These relationships suggest that the transfer of radiostrontium to foetuses and milk of free-ranging reindeer can be 3–4 times higher than observed in this experiment (due to lower Ca intake with natural forage), but the transfer to milk will not be as high as that of ionic ¹³⁴Cs. The concentrations of ⁸⁵Sr in milk suggested that the does mobilized skeletal stores of Ca and ⁸⁵Sr for milk production, although the diet appeared to satisfy the Ca requirements. In reindeer with radiostrontium intake during the whole year, radiostrontium concentrations in milk will therefore be higher than indicated by the F _m value observed in our study. No differences in half-times for ⁸⁵Sr and ¹³⁴Cs secretion in milk were detected. Both nuclides were secreted with short- and long-term half-times of 1–2 and 12–19 days, respectively. For ⁸⁵Sr, 80–90% of the activity was excreted with the short half-time, whereas the corresponding value for ¹³⁴Cs was 30–50%.     

Interaction of some Pd(II) complexes with Na+/K+-ATPase: Inhibition,kinetics, prevention and recovery

The aim of this work was to investigate the influence of [PdCl₄]^{2 ?} , [PdCl(dien)]⁺ and [PdCl(Me₄dien)]⁺ complexes on Na⁺/K⁺-ATPase activity. The dose-dependent inhibition curves were obtained in all cases. IC₅₀ values determined by Hill analysis were 2.25 × 10^{? 5} M, 1.21 × 10^{? 4} M and 2.36 × 10^{? 4} M, respectively. Na⁺/K⁺-ATPase exhibited typical Michelis-Menten kinetics in the presence of Pd(II) complexes. Kinetic parameters (V_max, K_m) derived using Eadie–Hofstee transformation indicated a noncompetitive type of Na⁺/K⁺-ATPase inhibition. The inhibitor constants (K_i) were determined from Dixon plots. The order of complex affinity for binding with Na⁺/K⁺-ATPase, deducted from K_i values, was [PdCl₄]^{2 ?} >[PdCl(dien)]⁺>[PdCl(Me₄dien)]⁺. The results indicated that the potency of Pd(II) complexes to inhibit Na⁺/K⁺-ATPase activity depended strongly on ligands of the related compound. Furthermore, the ability of SH-donor ligands, l-cysteine and glutathione, to prevent and recover the Pd(II) complexes-induced inhibition of Na⁺/K⁺-ATPase was examined. The addition of 1 mM l-cysteine or glutathione to the reaction mixture before exposure to Pd(II) complexes prevented the inhibition by increasing the IC₅₀ values by one order of magnitude. Moreover, the inhibited enzymatic activity was recovered by addition of SH-donor ligands in a concentration-dependent manner.     

Pd(II) complexes containing N-alkyl-3-pyridine-5-trifluoromethyl pyrazole ligands: Synthesis, NMR studies and X-ray crystal structures

Palladium [PdCl₂(L)] complexes with N-alkylpyridylpyrazole derived ligands [2-(5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L¹), 2-(1-ethyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L²), 2-(1-octyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L³), and 2-(3-pyridin-2-yl-5-trifluoromethyl-pyrazol-1-yl)ethanol (L⁴) were synthesised. The crystal and molecular structures of [PdCl₂(L)] (L = L², L³, L⁴) were resolved by X-ray diffraction, and consist of monomeric cis-[PdCl₂(L)] molecules. The palladium centre has a typical square-planar geometry, with a slight tetrahedral distortion. The tetra-coordinate metal atom is bonded to one pyridinic nitrogen, one pyrazolic nitrogen and two chlorine ligands in cis disposition. Reaction of L (L², L⁴) with [Pd(CH₃CN)₄](BF₄)₂, in the ratio 1M:2L, gave complexes [Pd(L)]₂(BF₄)₂. Treatment of [PdCl₂(L)] (L = L², L⁴) with NaBF₄ and pyridine (py) and treatment of the same complexes with AgBF₄ and triphenylphosphine (PPh₃) yielded [Pd(L)(py)₂](BF₄)₂ and [Pd(L)(PPh₃)₂](BF₄)₂ complexes, respectively. Finally, reaction of [PdCl₂(L⁴)] with 1 equiv of AgBF₄ yields [PdCl(L⁴)](BF₄).     

Biological activity of Pd(II) complexes with mono- and disubstituted pyridines—Experimental and theoretical studies

Due to the similarity between Pd and Pt, the complexes of palladium(II) can be considered as potential anticancer agents. Activity of six PdCl₂(X₂Py)₂ complexes (Py = pyridine, and X = CH₃ or Cl) was measured by MTT test using MCF7, CCRF-SB, PC3 and human B-lymphoblastoid cell lines. We found that the effect of PdCl₂(X_nPy)₂ was cell-specific and time-dependent. Obtained results were discussed and compared with the activation parameters calculated for the hydrolysis of PdCl₂(X_nPy)₂, indicating a correlation between viability of MCF7 and CCRF-SB cells and rates of hydrolysis of the Pd(II) complexes.     

Tissue distribution of 99mic-labeled liposomes prepared from synthetic amphiphiles containing amino acid residues

Abstract

The tissue distribution of ^99mTc-labeled liposomes prepared from synthetic amphiphiles containing amino acid residues was investigated for application to radiopharmaceuticals. The amphiphiles used were N,N-didodecyl-N α-[6-(trimethylammoniohexanoyl]-L-ala-ninamide bromide (N+C₅Ala2C₁₂), N,N-didodecyl-N_α-{6-[dimethyl(2-carboxyethyl)ammonio]hexanoyl}-L-alaninamide bromide (CAC₂N⁺C₅Ala2C₁₂) and S-{l-carboxy-2-([2,3-bis (he xadecyloxy)propoxy]carbony1)ethyl}homocy ste ine. These liposomes were stable in saline and 50% serum at 37° for at least 24h in comparison with the liposomes prepared from phosphatidylcholine and cholesterol (1:1). Most of the radioactivity of N+C₅Ala2C₁₂ and CAC₂N+C₅Ala2C₁₂ liposomes was firmly bound to Ehrlich ascites tumor cells in vitro. But the accumulation of three liposomes into the tumor of Ehrlich solid tumor-bearing mice after intravenous injection was low and most of the liposomes was taken up highly in liver and spleen which belong to the reticuloendothelial system (RES). Some approaches were made to reduce the RES uptake of N+C5Ala2C12 liposomes as follows: (1) the pretreatment of dextran sulfate depressed the uptake of the liposomes in the liver accompanied by increasing uptake in tumor and other tissues except stomach, (2) the modification of the liposomes with n-dodecyl glucoside or n-dodecyl sucrose depressed the uptake in liver and spleen, resulting in an increase in blood and other tissues such as tumor, duodenum and kidney, (3) the modification of the liposomes with ganglioside GM3 or GM1 reduced the uptake in liver and spleen, but increased scarcely the uptake in blood and tumor because of the rapid excretion into urine, (4) the intraperitoneal injection reduced the uptake of the liposomes in liver and increased significantly the accumulation in pancreas.     

Synthesis, X-ray crystal structure and NMR characterisation of mononuclear Pd(II) and Pt(II) complexes of didentate ligands with NN′-donor set

Two new 3,5-dimethylpyrazolic derived ligands that are N1-substituted by diamine chains, 1-[2-(diethylamino)ethyl]-3,5-dimethylpyrazole (L1) and 1-[2-(dioctylamino)ethyl]-3,5-dimethylpyrazole (L2) were synthesised. Reaction of the ligands, L1 and L2, with [MCl₂(CH₃CN)₂] yielded [MCl₂(L)] (M = Pd(II), Pt(II)) complexes. These complexes were characterised by elemental analyses, conductivity measurements, IR, ¹H, ¹³C{¹H} and ¹⁹⁵Pt{¹H} NMR spectroscopies. The crystal structure of [PdCl₂(L1)] was determined by single-crystal X-ray diffraction methods. The structure consists of mononuclear units. The Pd(II) atom is coordinated by a pyrazolic nitrogen, an amine nitrogen and two chlorine atoms in a cis disposition. In this structure, C-H?Cl, C-H?H-C and C-H?C-H intermolecular interactions have been identified.     

Effects of interaction between65Zn,cadmium, and copper in rats

Distribution and retention of zinc in the presence of cadmium and copper was studied in rats exposed repeatedly to these metals. The experiment was performed on white rats of the Wistar strain. The animals were divided into four groups/five rats each: 1)⁶⁵ZnCl₂; 2)⁶⁵ZnCl₂+CdCl₂; 3)⁶⁵ZnCl₂+CuCl₂; and 4) control group. Rats were administered sc every other day for two weeks:⁶⁵ZnCl₂−5 mg Zn/kg; CdCl₂−0,3 Cd/kg; and CuCl₂−2 mg Cu/kg. The zinc content was measured in rat tissues by γ-counting. Effect of Cd and Cu on subcellular distribution of zinc in the kidney and liver and on the level of metallothionein were also examined. Whole body retention of zinc under the influence of cadmium was lower than that observed in animals treated with zinc alone. However, copper increased twofold the whole body retention of zinc. Cadmium elevated the accumulation of zinc only in the kidneys nuclear fraction and liver soluble fraction. In the kidneys and liver, copper elevated the accumulation of zinc, in the nuclear, mitochondrial, and soluble fractions. The level of metallothionein-like proteins (MT) in the kidneys after a combined supply of zinc and copper was significantly increased with respect to the group of animals treated with zinc alone. These results indicated complex interactions between cadmium, copper, and zinc that can affect the metabolism of each of the metals.     

Synthesis, spectroscopic properties and structural characterisation of Pd(II) and Pt(II) complexes with 1,3,5-pyrazole derived ligands. Rotation around the metal-N bond

Reactions of ligands 1-ethyl-5-methyl-3-phenyl-1H-pyrazole (L¹) and 5-methyl-1-octyl-3-phenyl-1H-pyrazole (L²) with [PdCl₂(CH₃CN)₂ and K₂PtCl₄ gave complexes trans-[MCl₂(L)₂] (L = L¹, L²). The new complexes were characterised by elemental analyses, conductivity measurements, infrared, ¹H and ¹³C{¹H} NMR spectroscopies and X-ray diffraction. The NMR study of the complex [PdCl₂(L¹)₂], in CDCl₃ solution, is consistent with a very slow rotation of ligands around the Pd-N bond, so that two conformational isomers can be observed in solution (syn and anti). Different behaviour is observed for complexes [PdCl₂(L²)₂] and [PtCl₂(L)₂] (L = L¹, L²), which present an isomer in solution at room temperature (anti). The crystal structure of [PdCl₂(L¹)₂] complex is described, where the Pd(II) presents a square planar geometry with the ligands coordinated in a trans disposition.     

Reactivity of [PdCl(μ-med)]2 with monodentate or bidentate ligands. Structure of the dinuclear complexes [Pd(μ-med)(PPh3)]2(BF4)2 and [Pd(μ-med)(bpy)]2(BF4)2. [Hmed=N-(2-mercaptoethyl)-3,5-dimethylpyrazole]

Treatment of the ligand N-(2-mercaptoethyl)-3,5-dimethylpyrazole with [Pd(CH₃COO)₂]₃ and reaction of [PdCl(μ-med)]₂ with pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ produced the following complexes: [Pd(CH₃COO)(μ-med)]₂, [Pd(μ-med)(py)]₂(BF₄)₂ and [Pd(μ-med)(PPh₃)]₂(BF₄)₂. Similar reactions carried out with 2,2^′-bipyridine (bpy) or 1,3-bis(diphenylphosphino)propane (dppp) produced [Pd(μ-med)(bpy)]_x(BF₄)_x (x=1 or 2) and [Pd(μ-med)(dppp)]_x(BF₄)_x (x=1 or 2). Treatment of [Pd(μ-med)(bpy)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced [Pd₃Cl₂(μ-med)₂(bpy)₂](BF₄)₂. Treatment of [Pd(μ-med)(dppp)]_x(BF₄)_x with [PdCl₂(CH₃CN)₂] produced a mixture of [Pd(μ-Cl)(dppp)]₂(BF₄)₂ and [Pd(μ-med)₂(dppp)]²⁺. X-ray crystal structures of [Pd(μ-med)(PPh₃)]₂(BF₄)₂ · 2CH₃CN and [Pd(μ-med)(bpy)]₂(BF₄)₂ · 0.5CH₃OH are presented.     

Coupling of excitation and cessation of cyclois in Nitella: role of divalent cations

The effect of external divalent cation salt solutions upon the association of an action potential and cessation of cytoplasmic streaming in Nitella was studied. Nitella cells remained excitable when immersed in solutions of CaCl₂, MgCl₂, BaCl₂, and SrCl₂. Cessation of streaming coincident with excitation occurred in solutions of CaCl₂ or SrCl₂ but not in solutions of MgCl₂ or BaCl₂. In cells exposed to solutions containing mixtures of MgCl₂ and CaCl₂, or MgCl₂ and SrCl₂, it was the [Ca]/[Mg] or [Sr]/[Mg] which determined the effect of an action potential upon the rate of streaming, rather than the absolute concentrations Ca⁺⁺ or Sr⁺⁺. The implications of these data are discussed with respect to the structure involved in the generation of cytoplasmic streaming and the relation of streaming to other types of biological motion.     

Reaction of [MCl2(CH3CN)2] (M = Pd(II), Pt(II)) compounds with N1-alkylpyridylpyrazole-derived ligands

Palladium(II) and platinum(II) complexes with N-alkylpyridylpyrazole-derived ligands, 2-(1-ethyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L¹) and 2-(1-octyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L²), cis-[MCl₂(L)] (M = Pd(II), Pt(II)), have been synthesised. Treatment of [PdCl₂(L)] (L = L¹, L²) with excess of ligand (L¹, L²), pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ and NaBPh₄ produced the following complexes: [Pd(L)₂](BPh₄)₂, [Pd(L)(py)₂](BPh₄)₂ and [Pd(L)(PPh₃)₂](BPh₄)₂. All complexes have been characterised by elemental analyses, conductivity, IR and NMR spectroscopies. The crystal structures of cis-[PdCl₂(L²)] (2) and cis-[PtCl₂(L¹)] (3) were determined by a single crystal X-ray diffraction method. In both complexes, the metal atom is coordinated by one pyrazole nitrogen, one pyridine nitrogen and two chlorine atoms in a distorted square-planar geometry. In complex 3, π-π stacking between pairs of molecules is observed.     

Relation between the location of elements in the periodic table and various organ-uptake rates

Fifty four elements and 65 radioactive compounds were examined to determine the organ uptake rates for rats 3, 24 and 48 h after i.v. injection of these compounds. They were prepared as carrier free nuclides, or containing a small amount of stable nuclide.Generally speaking, behaviors of K, Rb, Cs and Tl in all the organs were very similar to one another, but they differed from that of Na. Bivalent hard acids were avidly taken up into bone; therefore, uptake rates in soft tissues were very small. Hard acids of tri-, quadri- and pentavalence which were taken up into the soft tissue organs decreased more slowly from these organs than other ions. Soft acids such as Hg²⁺ were bound very firmly to the component in the kidney. Anions (with few exceptions), GeCl₄ and SbCl₃ were rapidly excreted in urine, so that the uptake rates in organs were low.